As of 2025-09-18, the Intrinsic Value of Anavex Life Sciences Corp (AVXL) is -2.80 USD. This Anavex valuation is based on the model Peter Lynch Fair Value. With the current market price of 8.78 USD, the upside of Anavex Life Sciences Corp is -131.94%.
Based on its market price of 8.78 USD and our intrinsic valuation, Anavex Life Sciences Corp (AVXL) is overvalued by 131.94%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.80 - -2.80 | -2.80 | -131.94% |
| P/E | (7.48) - (7.78) | (7.77) | -188.5% |
| DDM - Stable | (3.59) - (8.64) | (6.12) | -169.7% |
| DDM - Multi | (0.97) - (1.81) | (1.26) | -114.4% |
| Market Cap (mil) | 754.11 |
| Beta | 1.33 |
| Outstanding shares (mil) | 85.89 |
| Enterprise Value (mil) | 652.95 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.38% |
| Cost of Debt | 5.00% |
| WACC | 8.69% |